Although a slight deficiency in ARSA activity, with levels 50–70 % that of controls, might be associated with pervasive developmental disorders, ARSA pseudodeficiency does not lead to neurological impairments [31]. The gene discussed is ARSA; the disease is Rare pervasive developmental disorder.